Abstract
ObjectivePulmonary arterial hypertension (PAH), caused by pulmonary artery remodelling and increased pulmonary vascular resistance (PVR) due to an unknown mechanism, is an intractable disease with a poor prognosis. The recent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have